Batislam, Ertan/0000-0002-7493-4573WOS: 000247454400009PubMed: 17593011\Purpose: The aim of this study was to investigate the effects of vardenafil on systemic blood pressure, intraocular pressure (IOP), and orbital hemodynamics. Methods: Twenty-one (21) volunteers suffering erectile dysfunction, with an average age of 51.5 +/- 6.2 years, were enrolled into the study. Brachial blood pressures and IOP were measured, the peak systolic velocity (PSV), end-diastolic velocity (EDV), and resistive index (RI) of the ophthalmic, central retinal, and posterior ciliary arteries were evaluated by color Doppler ultrasonography (CDU) before vardenafil intake. All measurements were repeated after 20 min of vardenafil intake. A paired Student t test was u...
INTRODUCTION: Sildenafil citrate is a type 5 phosphodiesterase inhibitor, which has demonstrated exc...
PURPOSE: To investigate if decrease of IOP affects the volumetric blood flow rate in the ophthalmic ...
Sepehr Bahadorani,1 Chelsey Krambeer,2 Kendall Wannamaker,1 Wayne Tie,1 Michael Jansen,1 Jason Espit...
Purpose: To investigate the effects of sildenafil, a popular new drug in the treatment of erectile d...
Background and aim: Sildenafil is used to treat erectile dysfunction but it has association with som...
It is known that the incidence of endothelial dysfunction in patients with vascular erectile dysfunc...
Sildenafil is the most prescribed oral agent for patients with erectile dysfunction (ED). Vardenafil...
Vardenafil is a new type of PDE5 inhibitor (PDE5I) with great inhibiting potential on PDE5 (IC50: 0....
Gernot Roessler, Michael Vobig, Peter Walter, Babac AE Mazinani Department of Ophthalmology, RWTH A...
Purpose: The purpose was to measure the retinal venous pressure (RVP) in both eyes of primary open-a...
Batislam, Ertan/0000-0002-7493-4573WOS: 000229592100003Objectives: In the present study, we aimed to...
Objective: To assess the effect of sildenafil citrate treatment on visual field analysis (VFA) in pa...
We read with great interest the article by Francesco Montorsi et al reviewing the literature on vard...
SUMMARY Vardenafil is a highly selective phosphodiesterase-5 (PDE-5) inhibitor approved for the trea...
The aim of this study was to investigate the effects of sildenafil on ocular hemodynamics by color D...
INTRODUCTION: Sildenafil citrate is a type 5 phosphodiesterase inhibitor, which has demonstrated exc...
PURPOSE: To investigate if decrease of IOP affects the volumetric blood flow rate in the ophthalmic ...
Sepehr Bahadorani,1 Chelsey Krambeer,2 Kendall Wannamaker,1 Wayne Tie,1 Michael Jansen,1 Jason Espit...
Purpose: To investigate the effects of sildenafil, a popular new drug in the treatment of erectile d...
Background and aim: Sildenafil is used to treat erectile dysfunction but it has association with som...
It is known that the incidence of endothelial dysfunction in patients with vascular erectile dysfunc...
Sildenafil is the most prescribed oral agent for patients with erectile dysfunction (ED). Vardenafil...
Vardenafil is a new type of PDE5 inhibitor (PDE5I) with great inhibiting potential on PDE5 (IC50: 0....
Gernot Roessler, Michael Vobig, Peter Walter, Babac AE Mazinani Department of Ophthalmology, RWTH A...
Purpose: The purpose was to measure the retinal venous pressure (RVP) in both eyes of primary open-a...
Batislam, Ertan/0000-0002-7493-4573WOS: 000229592100003Objectives: In the present study, we aimed to...
Objective: To assess the effect of sildenafil citrate treatment on visual field analysis (VFA) in pa...
We read with great interest the article by Francesco Montorsi et al reviewing the literature on vard...
SUMMARY Vardenafil is a highly selective phosphodiesterase-5 (PDE-5) inhibitor approved for the trea...
The aim of this study was to investigate the effects of sildenafil on ocular hemodynamics by color D...
INTRODUCTION: Sildenafil citrate is a type 5 phosphodiesterase inhibitor, which has demonstrated exc...
PURPOSE: To investigate if decrease of IOP affects the volumetric blood flow rate in the ophthalmic ...
Sepehr Bahadorani,1 Chelsey Krambeer,2 Kendall Wannamaker,1 Wayne Tie,1 Michael Jansen,1 Jason Espit...